The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

U.S. to approve of Pfizer COVID-19 vaccine in coming days -Azar

Fri, 11th Dec 2020 12:33

WASHINGTON, Dec 11 (Reuters) - U.S. approval of Pfizer Inc's
experimental COVID-19 vaccine should come within days,
with the first Americans getting immunized as early as Monday or
Tuesday, U.S. Health and Human Services Secretary Alex Azar said
on Friday.

Azar, speaking on ABC News's "Good Morning America" program,
added that the FDA had informed the drugmaker it planned to move
forward toward authorization. The federal government would also
work with the company to get the vaccine shipped out, he added.
(Reporting by Susan Heavey; Editing by Hugh Lawson)

Related Shares

More News
22 May 2024 09:53

LONDON BROKER RATINGS: Barclays cuts NextEnergy but lifts JLEN

(Alliance News) - The following London-listed shares received analyst recommendations Wednesday morning and on Tuesday:

22 May 2024 02:00

British firms expecting hard time in China market, lobby group warns

BEIJING, May 22 (Reuters) - British firms expect doing business in China to become harder over the next five years, a British business lobby group s...

21 May 2024 19:00

Sector movers: Stocks slip amid light profit-taking

(Sharecast News) - Stocks ended a tad lower as investors waited on a raft of US central bank speakers scheduled for after the close of markets in Lond...

21 May 2024 17:20

Europe's STOXX 600 ends lower as rate uncertainty prevails

Focus on Fed minutes, Nvidia earnings *

21 May 2024 17:04

LONDON MARKET CLOSE: London dips as eyes turn to UK inflation reading

(Alliance News) - Stock prices in London closed in the red on Tuesday, as investors nervously eye a key UK inflation reading, which could prompt the B...

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.